Dr Navid Malik, Executive director and head of research at the Live Sciences Division who works with Immupharma discusses their recent licence Agreement for Lupuzor with Avion in US – 10 December 2019
This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy